New treatments targeting the microbiota (FMT, antibiotics) – a case-based discussion4th P-ECCO Educational Course
2017
1
Omics analysis – Can we see the forest for the trees5th SciCom Workshop: Methodology on Research
2017
1
OP001: Whole genome sequencing and imputation in Inflammatory Bowel Disease identifies 26 novel loci and offers therapeutically-relevant mechanistic insightsECCO'17 Barcelona
2017
1
OP002: Epigenetic biomarkers to detect UC associated neoplasia: Results from phase I of the ENDCAP-C studyECCO'17 Barcelona
2017
1
OP003: Increased risk of acute arterial events in young patients with severely active Inflammatory Bowel Disease: A nationwide French cohort studyECCO'17 Barcelona
2017
1
OP004: Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn‘s DiseaseECCO'17 Barcelona
2017
1
OP005: The PROSIT cohort of infliximab biosimilar in IBD: A prolonged follow-up on the efficacy and safety across ItalyECCO'17 Barcelona
2017
1
OP006: Correlation of durability of response, serum trough concentrations and outcome parameters: Long-term follow-up of the Trough Concentration Adapted Infliximab Treatment (TAXIT) trialECCO'17 Barcelona
2017
1